Exchange: NYSE
-0.20% $74.10
America/New_York / 8 mai 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 37 830 mill |
EPS: | 0 |
P/E: | 0 |
Earnings Date: | N/A |
SharesOutstanding: | 510.53 mill |
Avg Daily Volume: | 1.160 mill |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 0 | sector: PE 23.85 |
PE RATIO: COMPANY / INDUSTRY |
---|
N/A |
Company: PE 0 | industry: PE 13.52 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 73.72 - 74.48 ( +/- 0.51%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2004-12-13 | Perseus Soros Biopharmaceutical Fund Lp | Sell | 750 000 | Series A Convertible Participating Preferred Stock |
2004-12-13 | Perseus Soros Biopharmaceutical Fund Lp | Buy | 1 500 000 | Common Stock, $0.0001 par value ("Common Stock") |
2004-12-13 | Perseus Soros Biopharmaceutical Fund Lp | Sell | 1 500 000 | Common Stock |
2006-06-21 | Dunker Kristen Marie | Sell | 55 000 | Option to purchase common stock |
2004-05-13 | Perseus Soros Biopharmaceutical Fund Lp | Buy | 375 044 | Common Stock, $0.001 par value per share |
INSIDER POWER |
---|
0.00 |
Last 6 transactions |
Buy: 1 950 053 | Sell: 2 305 000 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $74.10 (-0.20% ) |
Volume | 0.770 mill |
Avg. Vol. | 1.160 mill |
% of Avg. Vol | 66.36 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
This index includes all medium and larger issues of U.S. government, investment-grade corporate and investment-grade international dollar-denominated bonds that have maturities between 5 and 10 years and are publicly issued. All of the fund's investments will be selected through the sampling process, and at least 80% of its assets will be invested in bonds held in the index.